Telangana aims to emerge as 'lab of future' with $25 billion investments in life sciences sector

Telangana has set an ambitious goal to attract $25 billion in investments, generate five lakh jobs, and transform Hyderabad into a "Laboratory of the Future", a global hub for innovation-led life sciences growth.

The state unveiled these plans at the BioAsia 2026 conference on Tuesday. Under the theme "TechBio Unleashed: AI, Automation & the Biology Revolution," the two-day event examines how AI, advanced biology, and intelligent manufacturing are converging to transform therapy discovery, development, and delivery worldwide. BioAsia 2026 drew record participation, with over 4,000 delegates from 500 top life sciences companies worldwide.

Chief Minister A Revanth Reddy presented the Genome Valley Excellence Award to Prof. Bruce Levine, renowned professor from the University of Pennsylvania.

At Bio Asia 2026, major announcements were made by Opella Healthcare (France), Vaksindo Animal Health Pvt Ltd (division of JAPFA, Indonesia), Tredence Inc (USA), and Rx Propellant (RxP). The Swiss Pharmaceutical giant, Novartis unveiled a logo celebrating 25 years of its GCC presence in India with Hyderabad as its largest center globally outside its headquarters in Basel, Switzerland.

On the sidelines of the conference Chief minister A Revanth Reddy met the leadership teams from Miltenyi Biotec, Sanofi, MSD, Takeda along with the Consul General of Indonesia and team from Vaksindo, Indonesia.

“Telangana has established itself as a global leader in life sciences, pharmaceuticals, and healthcare. The Next Gen Life Sciences Policy 2026-30 emphasizes that future growth will be driven by cross-border collaboration, international capital, and shared innovation. This reflects the state's dedication to innovation and excellence. Telangana is developing a future-ready ecosystem that transforms scientific breakthroughs into practical healthcare solutions for India and the global community. This strategy aims to foster sustainable economic growth and reinforce the state's leadership in the global life sciences sector,” said chief minister, A Revanth Reddy after inaugurating Bio Asia conference.

State industries minister D Sridhar Babu, said that BioAsia 2026 stands as a premier platform uniting leading experts in healthcare and life sciences to explore innovative pathways for industry growth. “This event underscores Telangana's vision to catalyze industry advancement and establish a robust ecosystem that attracts global investments and talent, reinforcing its status as a key player in the global life sciences landscape. Telangana is committed to positioning itself as a preferred global hub for life sciences, leveraging strategic initiatives and collaborative efforts to foster innovation, research, and development,” said Sridhar Babu.

Investments announced at Bio Asia 2026:

Opella Healthcare, a global consumer healthcare company, spun off from Sanofi, with its global headquarters in France, and is expanding its GCC operations in a 42,000 sq. ft. facility, creating up to 500 jobs within the next year.

Vaksindo Animal Health Pvt Ltd, a division of JAPFA Indonesia, is establishing a state-ofthe-art BSL-3 vaccine manufacturing facility in Genome Valley. The facility will focus on producing vaccines for poultry, cattle, swine, and aquaculture.

Tredence Inc is an AI and data science company, is announcing its Hyderabad operations as a dedicated innovation hub focused on AI-driven healthcare and life sciences analytics. The facility will span approximately 18,000 sq. ft. and support its global operations.

Rx Propellant (RxP) to develop a new, large-format life sciences campus in Genome Valley, Hyderabad as part of its long-term commitment to strengthening India’s life sciences ecosystem. The project will comprise over 1 million square feet of advanced laboratory infrastructure spread across 12 acres of site delivered in phases over the next six years.